SCHEMBL7224174

SCHEMBL7224174

COc1n[nH]c(N)c1Cc1ccccc1-c1ccc2c(c1)OCO2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.45
MAPT P10636 3/20 0.45
ALDH1A1 P00352 2/20 0.45
NPC1 O15118 2/20 0.45
GAA P10253 1/20 0.45
ADORA1 P30542 3/20 0.41
ADORA2A P29274 2/20 0.41
LMNA P02545 3/20 0.41
USP2 O75604 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 2/20 0.41
ALOX15 P16050 2/20 0.41
TSHR P16473 2/20 0.41
CYP2C19 P33261 2/20 0.41
HSD17B10 Q99714 2/20 0.41
CYP2C9 P11712 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
CD274 Q9NZQ7 3/20 0.41
PDCD1 Q15116 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7040631 0.67 TAAR1 (0.54) KDM4EMAPTALDH1A1NPC1ADORA1
SCHEMBL395611 0.66 PTPRC (0.55) KDM4EMAPTALDH1A1NPC1ADORA1
SCHEMBL31366955 0.66 PTPRC (0.55) KDM4EMAPTALDH1A1NPC1ADORA1
SCHEMBL6048484 0.66 GABRA1 (0.49) KDM4EMAPTALDH1A1NPC1LMNA
Hydrochloric Acid SCHEMBL6048595 0.65 GABRA1 (0.48) KDM4EMAPTALDH1A1NPC1LMNA
SCHEMBL15020886 0.65 MAP2K4 (0.49) KDM4EMAPTALDH1A1NPC1GAA
SCHEMBL9308665 0.65 CD274 (0.52) KDM4EMAPTALDH1A1NPC1LMNA
SCHEMBL5282347 0.63 PTPRC (0.55) KDM4EMAPTALDH1A1NPC1LMNA
SCHEMBL1500077 0.63 KDR (0.57) KDM4EMAPTALDH1A1NPC1GAA
SCHEMBL6289617 0.62 CYP1A2 (0.50) KDM4EMAPTALDH1A1NPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6573270-B1 Endothelin receptor antagonists PFIZER INC. 2003-06-03 US disclosed